Psychoneuroendocrinology and psychoneuroimmunology of cancer: Plausible mechanisms worth pursuing?

Brain, Behavior, and Immunity

Volumn 17, Issue 1 SUPPL., 2003, Pages 84-91

  Antoni, Michael H ^a  

^a Department of Biology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN; HYDROCORTISONE; METHYLTRANSFERASE; TAMOXIFEN; TESTOSTERONE;

BEHAVIOR; BREAST CANCER; CANCER; CANCER GENETICS; CANCER GROWTH; CANCER RECURRENCE; CANCER RESEARCH; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL ACTIVITY; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; DISEASE PREDISPOSITION; DNA REPAIR; EMOTIONAL STRESS; ENZYME SYNTHESIS; FEAR; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DEFICIENCY; IMMUNOSURVEILLANCE; INFECTION; LYMPHOCYTE SUBPOPULATION; MENTAL STRESS; NATURAL KILLER CELL; NEUROENDOCRINOLOGY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROSTATE CANCER; PSYCHOPHYSIOLOGY; PSYCHOTRAUMA; QUALITY OF LIFE; SOCIAL PSYCHOLOGY; TUMOR PROMOTION; WART VIRUS; IMMUNOLOGY; IMMUNOMODULATION; NEOPLASM; NEUROSECRETION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

HUMANS; NEOPLASMS; NEUROIMMUNOMODULATION; NEUROSECRETORY SYSTEMS; PSYCHONEUROIMMUNOLOGY;

EID: 0037293192     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-1591(02)00074-0     Document Type: Conference Paper

References (68)

1. Andersen B., Kiecolt-Glaser J., Glaser R. A biobehavioral model of cancer stress and disease course. Am. Psychol. 49:1994;389-404.
2. Andersen B.L., Jochimsen P.R. Sexual functioning among breast cancer, gynecologic cancer, and healthy women. J. Consult. Clin. Psychol. 53:1985;25-32.
3. Andersen B., Farrar W., Golden-Kreutz D., Kutz L., MacCallum R., Courtney M.et al. Stress and immune responses after surgical treatment for regional breast cancer. J. Natl. Cancer Inst. 90:1998;30-36.
4. Antoni M.H., Lehman J., Kilbourn K., Boyers A., Yount S., Culver J.et al. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol. 20:2001;20-32.
5. Antoni M.H., Wagner S., Cruess D., Kumar M., Lutgendorf S., Ironson G.et al. Cognitive behavioral stress management reduces distress and 24-hour urinary free cortisol among symptomatic HIV-infected gay men. Ann. Behav. Med. 22:2000;29-37.
6. Antoni M.H., Goodkin K. Life stress and moderator variables in the promotion of cervical neoplasia. I: Personality facets. J. Psychosom. Res. 32(3):1988;327-338.
7. Antoni M.H., Goodkin K. Life stress and moderator variables in the promotion of cervical neoplasia. II: Life event dimensions. J. Psychosom. Res. 33(4):1989;457-467.
8. Barraclough J., Pinder P., Cruddas M., Osmond C., Taylor I., Perry M. Life events and breast cancer prognosis. Br. Med. J. 304:1992;1078-1081.
9. Bernstein L., Ross R. Endogenous hormones and breast cancer risk. Epidemiol. Rev. 15:1993;48-65.
10. Bovbjerg D., Valdimardottir V. Stress, immune modulation, and infectious disease during chemotherapy for breast cancer. Ann. Behav. Med. 18:1996;S63.
11. Bovbjerg D.H., Valdimarsdottir H.B. Psychoneuroimmunology: Implications for psycho-oncology. Holland J. Textbook of psycho-oncology. 1998;125-134 Oxford, New York.
12. Bovjberg D. Psychoneuroimmunology: Implications for oncology? Cancer. 67:1991;828-832.
13. Brenner B., Margolese R. The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer. Cancer. 68:1991;482-488.
14. Brinton L., Reeves W., Brenes M., Herrero R., deBritton R., Gaitan E.et al. Oral contraceptive use and risk of invasive cervical cancer. Int. J. Epidemiol. 19:1990;4-11.
15. Brisson J., Morin C., Fortier M., Roy M., Bouchard C., Leclerc J.et al. Risk factors for cervical intraepithelial neoplasia: Differences between low- and high-grade lesions. Am. J. Epidemiol. 140:1994;700-710.
16. Byrnes D., Antoni M.H., Goodkin K., Efantis-Potter J., Simon T., Munajj J.et al. Stressful events, pessimism, natural killer cell cytotoxicity, and cytotoxic/suppressor T-cells in HIV+ Black women at risk for cervical cancer. Psychosom. Med. 60:1998;714-722.
17. Castello G., Esposito G., Stellato G., Mora L.D., Abate G., Germano A. Immunological abnormalities in patients with cervical carcinoma. Gynecol. Oncol. 25:1986;61-64.
18. Cauley J., Lucas F., Kuller L., Stone K., Browner W., Cummings S. Elevated serum estradiaol and testorsterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group. Ann. Intern. Med. 130:1999;270-277.
19. Chuang L., Lotzova E., Cook K., Cristoforoni P., Morris M., Wharton J. Effect of new investigational drug taxol on oncolytic activity and stimulation of human lymphocytes. Gynecol. Oncol. 49:1993;291-298.
20. Clerici M., Shearer G., Clerici E. Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: Time to consider the TH1/TH2 paradigm. J. Natl. Inst. Cancer. 90:1998;261-263.
21. Cohen S., Tyrrell D.A., Smith A.P. Psychological stress in humans and susceptibility to the common cold. N. Eng. J. Med. 325:1991;606-612.
22. Cruess S., Antoni M.H., Hayes A., Penedo F., Ironson G., Fletcher M.A.et al. Changes in mood and depressive symptoms and related change processes during cognitive behavioral stress management in HIV-infected men. Cognit. Ther. Res. 26:2002;373-392.
23. Cruess D.G., Antoni M.H., McGregor B.A., Boyers A., Kumar M., Kilbourn K.et al. Cognitive-behavioral stress management reduces serum cortisol by enhancing positive contributions among women being treated for early stage breast cancer. Psychoso Med. 62:2000;304-308.
24. Fawzy F., Fawzy N., Hyun C., Elashoff R., Guthrie D., Fahey J.et al. Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch. Gen. Psychiat. 50:1993;681-689.
25. Fisher B., Costantino J., Wickerham D., Redmond C., Kavanah M., Cronin W.et al. Tamoxifen for prevention of breast cancer: Resport of the national surgical adjuvant breast and bowel project P-1 study. J. Natl. Cancer Inst. 90:1998;1371-1388.
26. Fonteneau J., Le Drean E., Le Guiner S., Gervois N., Diez E., Jotereau F. Heterogeneity of biologic responses of melanoma-specific CTL. J. Immunol. 159:1997;2831-2839.
27. Fowler F.J. Jr., Barry J.J., Lu-Yao G., Wasson J., Roman A., Wennberg J. Effect of radical prostatectomy for prostate cancer on patient quality of life: Results from a medicare survey. Urology. 45:1995;1007-1015.
28. Fossa S.D., Woehre H., Kurth K.H., Hetherington J., Bakke H., Rustad D.A.et al. Influence of urological morbidity on quality of life in patients with prostate cancer. Eur. Urol. 315:1997;3-8.
29. Gann P., Hennekens C., Loncope C., Stampfer M. Prospective study of sex hormone levels and risk of prostate cancer. J. Natl. Cancer Inst. 88:1996;1118-1126.
30. Garvy B., King L., Telford W., Morford L., Fraker P. Chronic elevation of plasma corticosterone causes reductions in the number of cycling cells of the B lineage in murine bone marrow and induces apoptosis. Immunology. 80:1993;587-592.
31. Glaser R., Thorn B., Tarr K., Kiecolt-Glaser J., D'Ambrosio S. Effects of stress on methyltransferase synthesis: An important DNA repair enzyme. Health Psychol. 4:1985;403-412.
32. Gorelik E., Herberman R. Immunological control of tumor metastases. Goldfarb R. Fundamental aspects of cancer. 1989;Kluwer Academic, Dordrecht.
33. Hays J.H., O'Brian J.T. Endocrine and metabolic function in patients with neoplastic disease. Herberman R.B. Influence of the host on tumor development. 1989;Kluwer Academic Publishers, Dordrecht.
34. Herbert T., Cohen S. Depression and immunity: A meta-analytic review. Psychol. Bull. 113:1993;472-486.
35. Herbert T., Cohen S. Stress and immunity in humans: A meta-analytic review. Psychosom. Med. 55:1993;364-379.
36. Ironson G., Antoni M.H., Lutgendorf S. Can psychological interventions affect immunity and survival. Present findings and suggested targets with a focus on cancer and human immunodeficiency virus. Mind/Body Med. 1(2):1995;85-110.
37. Katase K., Teshima H., Hirai Y., Hasumi K. Natural history of cervical human Papillomavirus lesions. Intervirology. 38:1995;192-194.
38. Key T. Hormones and cancer in humans. Mutat. Res. 333:1995;59-67.
39. Kiecolt-Glaser J., Marucha P., Malarkey W., Mercado A., Glaser R. Slowing of wound healing by psychological stress. Lancet. 346:1995;1194-1196.
40. Levy S., Herberman R., Lippman M., D'Angelo T., Lee J. Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Behav. Med. 1991;67-75.
41. Litwin M.S., Hays R.D., Fink A., Ganz P.A., Leake B., Leach G.E.et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 273:1995;129-135.
42. Maier S.F., Watkins L.R., Fleshner M. Psychoneuroimmunology: The interface between behavior, brain, and immunity. Am. Psychol. 49:1994;1004-1017.
43. McEwen B. Protective and damaging effects of stress mediators. N. Engl. J. Med. 338:1998;171-179.
44. McGregor, B., Antoni, M. H., Boyers, A., Alferi, S., Cruess, D., Blomberg, B., & et al. (in press). Effects of cognitive behavioral stress management on immune function and positive contributions in women with early-stage breast cancer. J. Psychosom. Res.
45. Melief C., Kast W. Cytotoxic T lymphocyte therapy of cancer and tumor escape mechanisms. Cancer Biol. 2:1991;347-353.
46. Miller J., Tessmer-Tuck J., Pierson B., Weisdorf D., McGlave P., Blazar B.et al. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity. Biol. Blood Marrow Transplant. 3:1997;34-44.
47. Penn I. Malignant lymphomas in organ transplant recipients. Transplant Proc. 13(1 pt 2):1981;736-738.
48. Pereira, D., Antoni, M. H., Simon, T., Efantis-Potter, J., Carver, C. S., Duran, R., & et al. (in press). Stress and squamous intraepithelial lesions in women with human Papillomavirus and human Immunodeficiency Virus. Psychosomatic Medicine.
49. Pollock R.E., Lotzova E., Stanford S.D. Surgical stress impairs natural killer cell programming of tumor for lysis in patients with sarcomas and other solid tumors. Cancer. 70:1992;2192-2202.
50. Pross, H., & Baines, M. (1988). Low natural killer cell activity in the peripheral blood of metastasis free cancer patients is associated with reduced metastasis free survival time. 19th Int. Leucocyte conference, Alberta.
51. Ramirez A., Craig T., Watson J., Fentiman I., North W., Rubens R. Stress and relapse of breast cancer. Br. Med. J. 298:1989;291-293.
52. Read G.F., Wilson D.W., Campbell F.C., Holliday H.W., Blamey R.W., Griffiths K. Salivary cortisol and dehydroepiandrosterone sulphate levels in postmenopausal women with primary breast cancer. Eur. J. Cancer Clin. Oncol. 19:1983;477-483.
53. Rogentine G., Van Krammen D., Fox B., Docherty J., Rosenblatt J., Boyd S.et al. Psychological factors in the prognosis of malignant melanoma: A prospective study. Psychosom. Med. 4:1979;647-655.
54. Schedlowski M., Jungk C., Schimanski G., Tewes U., Schmoll H.J. Effects of behavioral intervention on plasma cortisol and lymphocytes in breast cancer patients: An exploratory study. Psycho-Oncology. 3:1994;181-187.
55. Sephton S., Sapolski R., Kraemer H., Speigel D. Diurnal cortosil rhythm as a predictor of breast cancer survival. J. NCI. 92:2000;994-1000.
56. Spencer S., Lehman J., Wynings C., Arena P., Carver C.S., Antoni M.H.et al. Concerns about breast cancer and relations to psychological well-being in a multi-ethnic sample of early stage patients. Health Psychol. 18:1999;159-169.
57. Tay S., Jenkins D., Singer A. Natural killer cells in cervical intraepithelial neoplasia and human papillomavirus. Br. J. Obstet. Gynecol. 94:1987;901-906.
58. Tichatschek E., Zielinski C., Muller C.et al. Long-term influence of adjuvant therapy therapy on Natural Killer cell activty in breast cancer. Immunotherapy. 27:1988;278-282.
59. Tomei L., Kiecolt-Glaser J., Kenedy S., Glaser R. Psychological stress and phorbol ester inhibition of radiation-induced apoptosis in human peripheral blood leukocytes. Psychiat. Res. 33(1):1990;59-71.
60. Touitou Y., Levi F., Bogdan A., Benavides M., Bailleul F., Missett J.L. Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors. J. Cancer Res. Clin. Oncol. 121:1995;181-188.
61. Touitou Y., Bogdan A., Levi F., Benavides M., Auzeby A. Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: Relationships with tumour marker antigens. Br. J. Cancer. 74:1996;1248-1252.
62. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 47:1989;187.
63. Vermund S., Kelley K., Klein R., Feingold A., Schreiber K., Munk G.et al. High risk of human papillomavirus and cervical squamous intraepithelial lesions among women with human immunodeficiency virus infection. Am. J. Obstet. Gynecol. 165:1991;392-400.
64. Van der Pompe G., Antoni M.H., Heijnen C. The effects of surgical stress and psychological stress on the immune function of operative cancer patients. Psychol. Health. 13:1998;1015-1026.
65. Van der Pompe G., Antoni M.H., Duivenvoorden H., De Graeff R., Simonis T., van der Vegt F.et al. An exploratory study into the effect of group psychotherapy on cardiovascular and immunoreactivity to acute stress in breast cancer patients. PsychotherPsychosomatics. 70:2001;307-318.
66. Van der Pompe G., Antoni M.H., Heijnen C. The relations of plasma ACTH and cortisol levels with the distribution and function of peripheral blood cells in response to a behavioral challenge in breast cancer: An empirical exploration by means of statistical modelling. Int. J. Behav. Med. 4:1997;145-167.
67. Van der Pompe G., Antoni M.H., Mulder N., Heijnen C., Goodkin K., de Graeff A.et al. Psychoneuroimmunology and the course of breast cancer, an overview: The impact of psychosocial factors on progression of breast cancer through immune and endocrine mechanisms. Psycho-Oncology. 3:1994;271-288.
68. Van der Pompe G., Duivenvoorden H., Antoni M.H., Visser A., Heijnen C. Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients: An exploratory study. J. Psychosom. Res. 42:1997;453-466.